TransEnterix (TRXC) : 2 brokerage houses believe that TransEnterix (TRXC) is a Strong Buy at current levels. 1 Analyst considers the fundamentals to be worthy of a Buy recommendation. 1 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on TransEnterix (TRXC). Zacks Investment Research suggests a Buy with a rank of 2.The median of all the 4 Wall Street Analysts endorse the stock as a Buy with a rating of 1.75.
TransEnterix (TRXC) stock is expected to deviate a maximum of $0.9 from the average target price of $3.19 for the short term period. 4 Street Experts have initiated coverage on the stock with the most promising target being $4 and the most muted being $2.
Shares of TransEnterix, Inc. rose by 18.25% in the last five trading days and 29.6% for the last 4 weeks. TransEnterix, Inc. has dropped 13.83% during the last 3-month period . Year-to-Date the stock performance stands at -34.68%. TransEnterix (NYSEMKT:TRXC): stock turned positive on Tuesday. Though the stock opened at $1.45, the bulls momentum made the stock top out at $1.63 level for the day. The stock recorded a low of $1.38 and closed the trading day at $1.62, in the green by 13.29%. The total traded volume for the day was 1,668,248. The stock had closed at $1.43 in the previous days trading.
TransEnterix, Inc. is a medical device company focused on the development and commercialization of a robotic assisted surgical system called the SurgiBot System (the SurgiBot System). The Companys SurgiBot System is designed to utilize flexible instruments through articulating channels controlled directly by the surgeon with robotic assistance while the surgeon remains patientside within the sterile field. It has commercialized the SPIDER Surgical System, (the SPIDER System) a manual laparoscopic system in the United States, Europe and the Middle East. The SPIDER System utilizes flexible instruments and articulating channels that are controlled directly by the surgeon, allowing for multiple instruments to be introduced through a single site. It also offers Flex Ligating Shears (FLS) which is an energy device used with the existing SPIDER Surgical System. The FLS device is designed to deliver controlled energy to ligate and divide tissue.